...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix H2 2018 events

I'm going to try to update this events thread as needed for Resverlogix H2 2018 events. ASN, BIO-Europe and AHA are listed below for Oct/Nov 2018, but at this time it is not clear if a presentation opportunity is available for Resverlogix. Thanks to rndtbl over on Investor Village for the heads up on the October EASD. At the end of this message I list big conferences that are in H1 2019 to keep an eye on.....in particular ACC 2019.

 

Alzheimer's Association International Conference (AAIC) July 22-26, 2018; Chicago, IL

Poster Presentation July 23

"Apabetalone (An Epigenetic BET-Inhibitor Small Molecule): A Substudy Evaluating Effects on Cognition in Diabetes Patients with Cardiovascular Disease"

 

European Society of Cardiology (ESC) August 25-29, 2018; Munich, Germany

Symposium August 25th and Oral Presentation August 27th

Symposium: "LDL-c: Done Deal, Next Epigenetics?"

Oral Presentation "Apabetalone (RVX-208) Reduces Monocyte-Endothelial Cell Adhesion and Expression of Key Vascular Inflammation Markers in Monocytes, Endothelial Cells and in Inflamed Mouse Aorta" 

 

Clinical Trials on Alzheimer's Disease (CTAD)-Asia September 1-2, 2018; Shanghai, China

Oral presentation and Poster on September 1

Oral presentation: "Cognitive evaluation of treatment effects of the bromodomain and extra terminal domain inhibitor apabetalone: Design and baseline data of the cognition substudy of the BETonMACE Phase 3 cardiovascular trial.

Poster: "Effect of the BET Protein Inhibitor Apabetalone on Serum Markers of Potential Importance for Cognitive Decline in Cardiovascular Disease Patients."

 

Resverlogix and Zenith AGM's September 12, 2018

 

European Association for the Study of Diabetes (EASD) October 1-5, 2018

Oral Presentation October 3

"Apabetalone (RVX-208) an epigenetic modifier lowers risk of MACE in diabetes patients with CVD by affecting monocyte adhesion to endothelial cells"

 

American Society for Nephrology (ASN) October 23-28, 2018; San Diego, CA

 

BIO-Europe November 5-7, 2018; Copenhagen, Denmark

 

American Heart Association (AHA) November 10-12, 2018; Chicago, IL

 

2019 events to keep an eye on

Biotech Showcase January 7-9, 2018; San Francisco, CA

American College Cardiology (ACC) March 16-18, 2019; New Orleans, LA (note: Late-Breaking Clinical Trial Submissions are open Wednesday, Oct. 24 – Wednesday, Dec. 5, 2018). This is prime time possiblility for BETonMACE. First big cardio conference of the new year. Many big cardio outcomes trials present full trial results here.

BIO-Europe Spring March 25-27, 2018; Vienna, Austria

Vascular Discovery: From Genes to Medicine (Formerly ATVB:PVD): May 2019

European Renal Association – European Dialysis and Transplant Association (ERA-EDTA): June 2019

BIO-International June 2019

American Diabetes Association (ADA) June 2019

Share
New Message
Please login to post a reply